The management of pemphigus patients: Clinical remission, discontinuation of therapy and our experience Pemfigus hastalarinin takibi: Klinik remisyon, tedavinin sonlandirilmasi ve klinik deneyimimiz


Kavala M., ZİNDANCI İ.

Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.42, sa.SUPPL.1, ss.13-14, 2008 (Scopus, TRDizin)

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 42 Sayı: SUPPL.1
  • Basım Tarihi: 2008
  • Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.13-14
  • Anahtar Kelimeler: Clinical remission, Direct immunofluorescence, Indirect imunofluorescence, Pemphigus
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

The goal of therapy in pemphigus patients is to control the disease with appropriate medication and to discontinue the treatment. The best indicator of the treatment efficiency is mortality and the lenght of clinical remission. Because of the lack of reliable criteria to evaluate the partial or complete and sustained remission seen in pemphigus patients,it is difficult to decide the withdrawal of their drugs. When patients are in the active phase of the disease the main parameter for reducing the dose of drugs is clinical response When the patient is in clinical remission direct immunofluorescence test (DIF), valuable in the management of the disease, is used. Since a negative DIF finding implies immunologic remision of the disease, therapy can be discontinued in patients with negative results of DIF after a long period of clinical remission. In our series, 88 patients with pemphigus were examined for clinical remission and immunological activity. The indirect imunofluorescence (IIF) was positive in 34 patients. 54 patients who were in clinical remission, 26 patients had negative and 28 patients had positive results of DIF. Patients with negative results of DIF had their medications discontinued while patients with positive results continued their therapy. During the follow up period, 6 of 26 patients with negative DIF relapsed.